Cargando…

The signal-to-cutoff ratios to predict HCV infection among people who inject drugs

People who inject drugs (PWIDs) are primarily the high-risk population for HCV infection. This study aims to determine the optimal cut-off values for predicting HCV infection status based on the Signal-to-Cutoff (S/CO) ratio. In this study, a total of 719 PWIDs’ samples were collected, and performed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Bing, Gao, Ling-yu, Ma, Zhong-hui, Chang, Hao, Pei, Li-jian, Zhou, Qiang, Xing, Wen-ge
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer India 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9579682/ https://www.ncbi.nlm.nih.gov/pubmed/36278030 http://dx.doi.org/10.1007/s13337-022-00797-5

Ejemplares similares

Anti-HCV Signal-to-Cutoff Ratio in Predicting Hepatitis C Viremia
por: Kim, Hyon-Suk
Publicado: (2009)

Significance of Anti-HCV Signal-to-Cutoff Ratio in Predicting Hepatitis C Viremia
por: Seo, Yeon Seok, et al.
Publicado: (2009)

HCV and HIV co-infection among people who inject drugs in Vietnam
por: THINH, Vu Toan, et al.
Publicado: (2020)

HCV elimination among people who inject drugs. Modelling pre- and post–WHO elimination era
por: Gountas, Ilias, et al.
Publicado: (2018)

Barriers of linkage to HCV viremia testing among people who inject drugs in Georgia
por: Butsashvili, Maia, et al.
Publicado: (2022)

Molecular and spatial epidemiology of HCV among people who inject drugs in Boston, Massachusetts
por: Stopka, Thomas J., et al.
Publicado: (2022)

Injection partnership characteristics and HCV status associations with syringe and equipment sharing among people who inject drugs
por: Mackesy-Amiti, Mary Ellen, et al.
Publicado: (2023)

Gaps in HCV Knowledge and Risk Behaviors among Young Suburban People Who Inject Drugs
por: Jost, John J., et al.
Publicado: (2019)

Diverse HCV Strains And HIV URFS Identified Amongst People Who Inject Drugs In India
por: Rodgers, Mary A., et al.
Publicado: (2020)

Reported Low Uptake of HCV Testing among People Who Inject Drugs in Urban Vietnam
por: Thinh, Vu Toan, et al.
Publicado: (2020)

Modeling the role of incarceration in HCV transmission and prevention amongst people who inject drugs in rural Kentucky
por: Stone, Jack, et al.
Publicado: (2020)

In‐field evaluation of Xpert® HCV viral load Fingerstick assay in people who inject drugs in Tanzania
por: Mohamed, Zameer, et al.
Publicado: (2019)

Prevalence of HCV among people who inject drugs in Brussels—a respondent-driven sampling survey
por: Van Baelen, Luk, et al.
Publicado: (2020)

Outcomes of Real-World Integrated HCV Microelimination for People Who Inject Drugs: An expansion of the Punjab Model.
por: Dhiman, Radha K., et al.
Publicado: (2021)

Incidence of HIV and HCV in people who inject drugs: a systematic and meta-analysis review protocol
por: Sharhani, Asaad, et al.
Publicado: (2021)

Long-Term Persistence of Mitochondrial DNA Instability among HCV-Cured People Who Inject Drugs
por: Durand, Mélusine, et al.
Publicado: (2022)

Gender Differences in HIV, HCV risk and Prevention Needs Among People who Inject drug in Vietnam
por: Giang, Hoang Thi, et al.
Publicado: (2022)

Comparison of the Efficacies of Direct-Acting Antiviral Treatment for HCV Infection in People Who Inject Drugs and Non-Drug Users
por: Hsu, Jui-Ting, et al.
Publicado: (2022)

CHIME - A tailored HCV microelimination project in Viennese people who inject drugs at drug centralized substitution centers
por: Schwarz, Caroline, et al.
Publicado: (2023)

Modelling the impact of incarceration and prison‐based hepatitis C virus (HCV) treatment on HCV transmission among people who inject drugs in Scotland
por: Stone, Jack, et al.
Publicado: (2017)

The Role of the Signal-to-Cutoff Ratio in Automated Anti-HCV Chemiluminescent Immunoassays by Referring to the Nucleic Acid Amplification Test and the Recombinant Immunoblot Assay
por: Choi, Moon Suk, et al.
Publicado: (2018)

HCV incidence is associated with injecting partner age and HCV serostatus mixing in young adults who inject drugs in San Francisco
por: Page, Kimberly, et al.
Publicado: (2019)

Co-infections and transmission networks of HCV, HIV-1 and HPgV among people who inject drugs
por: Tien Ng, Kim, et al.
Publicado: (2015)

Public Health Considerations among People who Inject Drugs with HIV/HCV Co-Infection: A Review
por: Murdock, Rachel M., et al.
Publicado: (2019)

Evidence-based and guideline-concurrent responses to narratives deferring HCV treatment among people who inject drugs
por: Childs, Ellen, et al.
Publicado: (2019)

Mobile Technology to Increase HIV/HCV Testing and Overdose Prevention/Response among People Who Inject Drugs
por: Aronson, Ian David, et al.
Publicado: (2017)

A CCL5 Haplotype Is Associated with Low Seropositivity Rate of HCV Infection in People Who Inject Drugs
por: Huik, Kristi, et al.
Publicado: (2016)

Pilot Outreach Program in Remedis—The Promising Step toward HCV Elimination among People Who Inject Drugs
por: Krekulová, Laura, et al.
Publicado: (2022)

Confirmation of HCV viremia using HCV RNA and core antigen testing on dried blood spot in HIV infected peoples who inject drugs in Vietnam
por: Nguyen, Truong Tam, et al.
Publicado: (2018)

Hepatitis C virus care cascade among people who inject drugs in puerto rico: Minimal HCV treatment and substantial barriers to HCV care
por: Aponte-Meléndez, Yesenia, et al.
Publicado: (2023)

Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review
por: Degenhardt, Louisa, et al.
Publicado: (2017)

Are Interferon-Free Direct-Acting Antivirals for the Treatment of HCV Enough to Control the Epidemic among People Who Inject Drugs?
por: Lima, Viviane D., et al.
Publicado: (2015)

Inactivation of HCV and HIV by microwave: a novel approach for prevention of virus transmission among people who inject drugs
por: Siddharta, Anindya, et al.
Publicado: (2016)

HCV prevalence can predict HIV epidemic potential among people who inject drugs: mathematical modeling analysis
por: Akbarzadeh, Vajiheh, et al.
Publicado: (2016)

Elimination of HCV as a public health concern among people who inject drugs by 2030 – What will it take to get there?
por: Grebely, Jason, et al.
Publicado: (2017)

HCV/HIV coinfection among people who inject drugs and enter opioid substitution treatment in Greece: prevalence and correlates
por: Fotiou, Anastasios, et al.
Publicado: (2016)

Establishing trust in HIV/HCV research among people who inject drugs (PWID): Insights from empirical research
por: Abadie, Roberto, et al.
Publicado: (2018)

Modelling the impact of HIV and HCV prevention and treatment interventions for people who inject drugs in Dar es Salaam, Tanzania
por: Fraser, Hannah, et al.
Publicado: (2021)

“Maintaining HIV and HCV prevention and care for people who inject drugs despite COVID‐19 in Hai Phong, Vietnam”
por: Giang, Hoang Thi, et al.
Publicado: (2022)

HCV Genotype Distribution Among People Who Inject Drug in Turkey: Findings from Multicenter and Cross-Sectional Study
por: Dilbaz, Nesrin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ba0k0188pieon3otr5vjes4bld